What’s new in atopic eczema? An analysis of systematic reviews published in 2009–2010

@article{Shams2011WhatsNI,
  title={What’s new in atopic eczema? An analysis of systematic reviews published in 2009–2010},
  author={Kave Shams and Douglas J. C. Grindlay and Hywel C. Williams},
  journal={Clinical and Experimental Dermatology},
  year={2011},
  volume={36}
}
This review provides a summary of key findings from 18 systematic reviews on atopic eczema, published or indexed between January 2009 and 24 August 2010. There was no good evidence on the possible benefit of organic food consumption and eczema. Maternal intake of fish or fish oil may be associated with a reduced risk of eczema in offspring, although further studies are needed. There is some evidence that partially hydrolysed infant formulas rather than standard formulas may be associated with a… 
What’s new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009
TLDR
Two systematic reviews concluded that there is a strong and consistent association between filaggrin (FLG) mutations and development of eczema, and supplementation with omega‐3 and omega‐6 oils is unlikely to play an important role in the primary prevention of Eczema or allergic diseases in general.
What's new in atopic eczema? An analysis of systematic reviews published in 2010–11
TLDR
There is no clear evidence for the efficacy of homeopathy, botanical extracts or Chinese herbal medicine in the treatment of AE, as large well‐designed trials are lacking in these areas.
What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention
TLDR
There is now clear evidence that evening primrose oil and borage oil are not effective for the treatment of AE, and the most promising intervention for the prevention of AE is the use of probiotics during the late stages of pregnancy and early life.
What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema
This review summarizes clinically important findings from nine systematic reviews indexed in bibliographical databases between August 2007 and August 2008, dealing with the definitions, causes and
What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 1. Epidemiology, mechanisms of disease and methodological issues
TLDR
There is now reasonable evidence to suggest that antibiotic exposure in early life is associated with increased incidence of AE, but delivery by caesarean section is not, and a standardized definition of an incident case of AE for use in prevention studies is still required.
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews
TLDR
The aims of this overview are to synthesize the current evidence of published systematic reviews (SRs) on nonallergic comorbidities of atopic eczema and to clarify the relationship of AE with Th1‐ and Th17‐mediated (auto‐)inflammatory conditions such as diabetes mellitus type 1 and MS.
Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review
TLDR
The efficacy of immunotherapy in patients with atopic eczema has been poorly investigated in the past 5 years, and the available trials have small dimension and some methodological shortcomings, in addition to incomplete reporting.
Management of difficult and severe eczema in childhood
TLDR
There is a distinct lack of evidence to help guide the clinician caring for children with eczema, with around 2% of patients have severe disease that does not respond to topical anti-inflammatory drugs or ultraviolet light treatment alone.
Mapping Systematic Reviews on Atopic Eczema—An Essential Resource for Dermatology Professionals and Researchers
TLDR
An on-line resource that includes all relevant eczema reviews published since 2000 is compiled to help healthcare practitioners, guideline writers, information specialists, and researchers to quickly identify relevant up-to-date evidence in the field for improving patient care.
...
...

References

SHOWING 1-10 OF 27 REFERENCES
What’s new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009
TLDR
Two systematic reviews concluded that there is a strong and consistent association between filaggrin (FLG) mutations and development of eczema, and supplementation with omega‐3 and omega‐6 oils is unlikely to play an important role in the primary prevention of Eczema or allergic diseases in general.
What’s new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007
TLDR
The evidence suggests that avoidance of allergenic foods during pregnancy or the use of hydrolyzed or soy formula milks does not prevent Eczema, and delayed introduction of solids may decrease eczema risk.
What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment
TLDR
Clinical important findings from systematic reviews indexed in bibliographical databases between August 2007 and August 2008 that dealt with disease prevention and treatment of atopic eczema are summarized.
What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema
This review summarizes clinically important findings from nine systematic reviews indexed in bibliographical databases between August 2007 and August 2008, dealing with the definitions, causes and
The diagnosis and management of food allergy.
  • A. Cant
  • Medicine
    Archives of disease in childhood
  • 1986
TLDR
It is still unclear what proportion of children with conditions reputed to be caused by food allergy will benefit from dietary measures, and the importance of making a firm diagnosis before keeping a child on a restricted diet is highlighted.
Partially Hydrolyzed 100% Whey Protein Infant Formula and Reduced Risk of Atopic Dermatitis: A Meta-analysis
TLDR
For infants who are not exclusively breast-fed, feeding with PHF-W instead of CMF reduces the risk of AD in infants, particularly in infants with a family history of allergy.
Partially hydrolyzed 100% whey protein infant formula and atopic dermatitis risk reduction: a systematic review of the literature.
TLDR
The cumulative incidence of AD was significantly lower among infants over at least 3 years of follow-up in the PHF-W group compared with the intact protein cow's milk group, and Exclusive breastfeeding should be encouraged as the primary means to prevent atopic risk.
Diagnosing and managing common food allergies: a systematic review.
TLDR
The evidence for the prevalence and management of food allergy is greatly limited by a lack of uniformity for criteria for making a diagnosis and a failure to recommend use of immunotherapy.
Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials
TLDR
Both tacrolimus ointment and pimecrolimus cream are safe and effective in the treatment of AD in pediatric patients.
The association between atopy and childhood/adolescent leukemia: a meta-analysis.
TLDR
The authors performed a meta-analysis of associations between atopy/allergies, asthma, eczema, hay fever, and hives and childhood/adolescent leukemia, acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML), finding results useful in designing future research.
...
...